These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38781924)

  • 21. Impact of the COVID-19 pandemic on infectious diseases reporting.
    Contarino F; Bella F; DI Pietro E; Randazzo C; Contrino ML
    J Prev Med Hyg; 2024 Jun; 65(2):E145-E153. PubMed ID: 39430999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the Incidence of Intussusception and Infectious Diseases After the COVID-19 Pandemic in Korea.
    Yoo IH; Kang HM; Jeong DC
    J Korean Med Sci; 2022 Feb; 37(8):e60. PubMed ID: 35226418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.
    Liu W; Wang R; Li Y; Zhao S; Chen Y; Zhao Y
    BMC Public Health; 2023 Jun; 23(1):1089. PubMed ID: 37280569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronavirus Disease Exposure and Spread from Nightclubs, South Korea.
    Kang CR; Lee JY; Park Y; Huh IS; Ham HJ; Han JK; Kim JI; Na BJ;
    Emerg Infect Dis; 2020 Oct; 26(10):2499-2501. PubMed ID: 32633713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological characteristics of respiratory viruses in hospitalized children during the COVID-19 pandemic in southwestern China.
    Zhu L; Luo T; Yuan Y; Yang S; Niu C; Gong T; Wang X; Xie X; Luo J; Liu E; Fu Z; Tian D
    Front Cell Infect Microbiol; 2023; 13():1142199. PubMed ID: 37153160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of COVID-19 public health measures on nationally notifiable diseases in Australia during 2020 and 2021.
    Rafferty AC; Glynn-Robinson A; Thangarajah D; Polkinghorne B
    Commun Dis Intell (2018); 2024 Jul; 48():. PubMed ID: 39021122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden changes in notifiable infectious diseases in Taiwan during the COVID-19 pandemic.
    Yang YF; Chen YM; Chen SY; Chiu PH; Chen SC
    PeerJ; 2024; 12():e18048. PubMed ID: 39267943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021.
    Yi S; Choe YJ; Kim J; Kim YY; Kim RK; Jang EJ; Lim DS; Byeon HR; Lee S; Park E; Kim SJ; Park YJ
    Emerg Infect Dis; 2022 Mar; 28(3):753-756. PubMed ID: 35202529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic.
    Li K; Rui J; Song W; Luo L; Zhao Y; Qu H; Liu H; Wei H; Zhang R; Abudunaibi B; Wang Y; Zhou Z; Xiang T; Chen T
    Nat Commun; 2024 May; 15(1):3891. PubMed ID: 38719858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of COVID-19 Pandemic on the Incidence of Pediatric Acute Otitis Media in Seoul, South Korea.
    Lee HJ; Mun SK; Chang M
    Otol Neurotol; 2023 Oct; 44(9):912-917. PubMed ID: 37590882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of national COVID-19 restrictions on incidence of notifiable communicable diseases in England: an interrupted time series analysis.
    Nash K; Lai J; Sandhu K; Chandan JS; Shantikumar S; Ogunlayi F; Coleman PC
    BMC Public Health; 2022 Dec; 22(1):2318. PubMed ID: 36510205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological changes in infectious diseases during the coronavirus disease 2019 pandemic in Korea: a systematic review.
    Ahn JG
    Clin Exp Pediatr; 2022 Apr; 65(4):167-171. PubMed ID: 34844396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying the Impact of COVID-19 Nonpharmaceutical Interventions on Influenza Transmission in the United States.
    Qi Y; Shaman J; Pei S
    J Infect Dis; 2021 Nov; 224(9):1500-1508. PubMed ID: 34551108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021.
    Miller MJ; Himschoot A; Fitch N; Jawalkar S; Freeman D; Hilton C; Berney K; Guy GP; Benoit TJ; Clarke KEN; Busch MP; Opsomer JD; Stramer SL; Hall AJ; Gundlapalli AV; MacNeil A; McCord R; Sunshine G; Howard-Williams M; Dunphy C; Jones JM
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S264-S270. PubMed ID: 35684974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19.
    Bendavid E; Oh C; Bhattacharya J; Ioannidis JPA
    Eur J Clin Invest; 2021 Apr; 51(4):e13484. PubMed ID: 33400268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data.
    Ravkin HD; Yom-Tov E; Nesher L
    J Med Internet Res; 2022 Dec; 24(12):e42781. PubMed ID: 36476385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonpharmaceutical Interventions Used to Control COVID-19 Reduced Seasonal Influenza Transmission in China.
    Lei H; Xu M; Wang X; Xie Y; Du X; Chen T; Yang L; Wang D; Shu Y
    J Infect Dis; 2020 Nov; 222(11):1780-1783. PubMed ID: 32898256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of common infectious diseases in Japan during the COVID-19 pandemic.
    Hibiya K; Iwata H; Kinjo T; Shinzato A; Tateyama M; Ueda S; Fujita J
    PLoS One; 2022; 17(1):e0261332. PubMed ID: 35020724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong.
    Chiu SS; Cowling BJ; Peiris JSM; Chan ELY; Wong WHS; Lee KP
    Emerg Infect Dis; 2022 Jan; 28(1):62-68. PubMed ID: 34932446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality trends in people with disabilities before and during the COVID-19 pandemic in South Korea, 2017-2022.
    Kim YS; Kim JH; Kwon S; Kim JH; Kim HJ; Ho SH
    Front Public Health; 2024; 12():1414515. PubMed ID: 39118973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.